Total Payments
$2,175
2024 Payments
$1,448
Companies
21
Transactions
140
Medicare Patients
968
Medicare Billing
$115,443
Payment Breakdown by Category
Food & Beverage$2,155 (99.1%)
Other$20.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,155 | 139 | 99.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $331.16 | 28 | $0 (2024) |
| PFIZER INC. | $293.93 | 17 | $0 (2024) |
| ABBVIE INC. | $249.24 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $220.79 | 13 | $0 (2024) |
| GENZYME CORPORATION | $197.29 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $145.67 | 9 | $0 (2024) |
| Lilly USA, LLC | $139.55 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $90.33 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $72.25 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $66.96 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,448 | 93 | PFIZER INC. ($209.88) |
| 2023 | $726.79 | 47 | Celgene Corporation ($175.67) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: GI | ||||||
| 12/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: GI COLON PREP | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.24 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: LIVER DISEASE | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 710 | 903 | $506,001 | $81,662 |
| 2022 | 5 | 258 | 409 | $166,846 | $33,780 |
Total Patients
968
Total Services
1,312
Medicare Billing
$115,443
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 176 | 315 | $72,450 | $20,641 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 141 | 149 | $65,262 | $15,245 | 23.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 74 | $24,568 | $7,339 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 55 | $19,195 | $5,678 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 65 | $103,675 | $5,401 | 5.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $70,785 | $4,739 | 6.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $41,745 | $4,529 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $14,080 | $4,255 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $15,158 | $3,469 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 43 | $10,105 | $3,047 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $11,264 | $2,382 | 21.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $27,104 | $2,028 | 7.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $25,410 | $1,802 | 7.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $5,200 | $1,108 | 21.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 106 | $46,428 | $11,935 | 25.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 124 | $41,168 | $10,407 | 25.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 148 | $34,040 | $8,726 | 25.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 20 | $31,900 | $1,618 | 5.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $13,310 | $1,095 | 8.2% |
About Dr. Andrew Kruger, DO
Dr. Andrew Kruger, DO is a Gastroenterology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821450388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Kruger, DO has received a total of $2,175 in payments from pharmaceutical and medical device companies, with $1,448 received in 2024. These payments were reported across 140 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,155).
As a Medicare-enrolled provider, Kruger has provided services to 968 Medicare beneficiaries, totaling 1,312 services with total Medicare billing of $115,443. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Oakhurst, NJ
- Active Since 03/24/2016
- Last Updated 02/17/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1821450388
Products in Payments
- ZEPOSIA (Drug) $331.16
- DUPIXENT (Biological) $269.54
- XELJANZ (Drug) $226.50
- OMVOH (Drug) $139.55
- ENTYVIO (Biological) $119.36
- RINVOQ (Biological) $113.91
- EOHILIA (Drug) $84.66
- TREMFYA (Drug) $72.55
- VELSIPITY (Drug) $67.43
- DIFICID (Drug) $66.96
- INJECTAFER (Drug) $63.36
- XIFAXAN (Drug) $62.93
- STELARA (Biological) $56.83
- RESMETIROM (Drug) $48.60
- VOWST (Biological) $48.06
- IQIRVO (Drug) $46.10
- CYLTEZO (Drug) $43.87
- SKYRIZI (Biological) $34.44
- LINZESS (Drug) $31.39
- TRULANCE (Drug) $27.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakhurst
Laleh Merikhi, M.d, M.D
Gastroenterology — Payments: $13,511
Gastroenterology $13,511
Ben Terrany, Md, MD
Gastroenterology — Payments: $9,191
Gastroenterology $9,191
Junsuke Maki, Md, MD
Gastroenterology — Payments: $6,862
Gastroenterology $6,862
Dr. Mitchell Schwartz, M.d, M.D
Gastroenterology — Payments: $2,458
Gastroenterology $2,458
Shamina Dhillon, M.d, M.D
Gastroenterology — Payments: $2,446
Gastroenterology $2,446
Dr. Penny Turtel, Md, MD
Gastroenterology — Payments: $2,429
Gastroenterology $2,429